SNGX
Soligenix, Inc.
$0.38
-0.01 (-2.56%)
At close · Jul 6
Market Cap
$5.72M
Shares
14,824,174
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.38
Open$0.39
Day$0.38–0.40
52W$0.28–6.23
Avg vol 30d14.2M
Short int479K · 3.2% float · 1.0d
Short vol34%
DataJan 2020–Jul 2026
Filing10-Q · May 8
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−67% below
−
Price vs 50-day avg
−24% below
◦
RSI (14)
39 · neutral
+
MACD trend
positive
−
52-week position
2% · near low
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $0 › 200d $1 — 200d above 50d
−
Institutional flow
-21% holders QoQ · +4 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
3.23% of float · ▼ -92.6% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
15 holders — mid 2-yr range
Fundamentals
Strong
−
Revenue growth
−86% Y/Y
+
Gross margin
82%, expanding
+
EPS growth
+57% Y/Y
−
Free cash flow
$-10.3M
+
Balance sheet
net cash $26.0M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 8, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−67% below
Bearish
Price vs 50-day avg
−24% below
Bearish
RSI (14)
39 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
2% · near low
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-21% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.23% of float · ▼ -92.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 2-yr range
Price context
position in its 52-week range
52-wk low $0
Now $0 · 2%
52-wk high $6
vs 200-day avg -67%
vs 50-day avg -24%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SNGX
this stock
Soligenix, Inc.
|
$5.72M | -71.6% | -85.8% | — | 3.2% |
|
ONC
BeOne Medicines Ltd.
|
$488.96B | +1.9% | +22179.2% | 995.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.1 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SNGX | -7.3% | -20.8% | -71.9% | -5.0% | -71.6% |
| SPY | +3.1% | -0.8% | +8.2% | +0.6% | +10.2% |
| vs SPY | -10.4% | -20.1% | -80.1% | -5.6% | -81.8% |